Share
   
Title
Code
Session Type
Venue
Date Time
Co-Chairs:
16:30
MOAB0407
Introductory remarks
Marijke Wijnroks, Switzerland
16:35
MOAB0401
Gaps and opportunities in policy and practice in 20 countries with the highest burden of HIV-associated TB
Annabel Baddeley, Switzerland
Abstract
Slides
16:49
MOAB0402
Genomic epidemiology of extensively drug-resistant tuberculosis in KwaZulu-Natal, South Africa: demographic expansion and genetic determinants of epidemiologic success in a high HIV prevalence setting
Tyler S. Brown, United States
Abstract
Slides
17:03
MOAB0403
Incidence of tuberculosis in the first year of antiretroviral treatment in West-African HIV-infected adults
Boris Tchakounte Youngui, France
Abstract
Slides
17:17
MOAB0404
Time to treatment initiation for drug-resistant tuberculosis is delayed in a South African prospective cohort
Brittney J. Sullivan, United States
Abstract
17:31
MOAB0405
High uptake of antiretroviral therapy among HIV-positive TB patients receiving co-located services in Swaziland
Ishani Pathmanathan, United States
Abstract
Slides
17:45
MOAB0406
Feasibility of using determine-TB LAM test in HIV-infected adults in programmatic conditions
Sekai Chenai Mathabire, France
Abstract
Slides